4.3 Review

A Delphi consensus statement for the management of post-COVID interstitial lung disease

Related references

Note: Only part of the references are listed.
Review Allergy

A Review of Persistent Post-COVID Syndrome (PPCS)

Bryan Oronsky et al.

Summary: Persistent post-COVID syndrome, a pathologic entity, involves persistent physical, medical, and cognitive sequelae following COVID-19. The syndrome includes immunosuppression and organ fibrosis, and its potential long-term effects place a burden on healthcare systems, patients' families, and society.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)

Review Medicine, General & Internal

Post COVID-19 pulmonary fibrosis; a meta-analysis study

Bnar J. Hama Amin et al.

Summary: This meta-analysis study found that approximately 44.9% of COVID-19 survivors developed pulmonary fibrosis, and the severity of COVID-19 was significantly associated with the development of PCPF.

ANNALS OF MEDICINE AND SURGERY (2022)

Article Medicine, General & Internal

An integrated multidisciplinary model of COVID-19 recovery care

Helen O'Brien et al.

Summary: This article describes the establishment of a COVID Recovery Service in Ireland, which aims to provide comprehensive follow-up for patients with a hospital diagnosis of COVID-19 pneumonia. It uses a hybrid model of virtual and in-person clinics supported by a multidisciplinary team to identify patients in need of enhanced follow-up and provide support for those with complications of COVID-19 and requiring integrated community care. The early data suggests that a significant proportion of discharged patients will require medium to long-term specialist follow-up, indicating the importance of an integrated multidisciplinary approach to address the physical and mental healthcare needs of COVID-19 patients.

IRISH JOURNAL OF MEDICAL SCIENCE (2021)

Review Physiology

Healing after COVID-19: are survivors at risk for pulmonary fibrosis?

Lindsay T. McDonald

Summary: The novel SARS-CoV-2 coronavirus, responsible for COVID-19, was first reported in Wuhan, China, in December 2019, and the World Health Organization declared a pandemic by March 2020. Concerns have been raised about potential long-term effects of COVID-19 on respiratory health, but with limited data available, predictions on long-term outcomes remain speculative. Improved recognition of potential risk factors for fibrotic disease through studying previous coronavirus outbreaks is crucial in understanding the potential long-term implications of COVID-19.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)

Article Respiratory System

Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial

Thomas Sonnweber et al.

Summary: A study found that some COVID-19 patients still experienced persistent symptoms and lung function impairment 100 days after the onset of the disease, but there was significant improvement in symptoms and cardiopulmonary status over time.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia

Xiaoyu Han et al.

Summary: The study found that over one-third of severe COVID-19 patients showed fibrotic-like changes in the lung at 6-month follow-up CT, which were associated with older age, acute respiratory distress syndrome, longer hospital stays, tachycardia, noninvasive mechanical ventilation, and higher initial chest CT score.

RADIOLOGY (2021)

Editorial Material Medicine, General & Internal

Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline

Waqaar Shah et al.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Review Critical Care Medicine

Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19

Ranju T. Dhawan et al.

Summary: COVID-19 is associated with pulmonary thrombosis and thromboembolism, potentially leading to pulmonary fibrotic damage and long-term consequences. A proactive follow-up strategy is needed to evaluate residual clot burden, small vessel injury, and potential hemodynamic sequelae. A nuanced and physiological approach to follow-up imaging is crucial for informing therapeutic strategies in case of clinically significant pulmonary vascular sequelae.

LANCET RESPIRATORY MEDICINE (2021)

Article Biochemistry & Molecular Biology

Attributes and predictors of long COVID

Carole H. Sudre et al.

Summary: Reports on long-lasting COVID-19 symptoms, known as 'long COVID', are increasing. Analysis of data from over 4,000 COVID-19 cases revealed that long COVID is more common in older individuals, those with higher body mass index, and females. Experiencing more than five symptoms in the first week of illness was associated with long COVID. A simple model showed promise in distinguishing between short and long COVID cases early in the disease.

NATURE MEDICINE (2021)

Article Medicine, General & Internal

Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19

Luc Morin et al.

Summary: After 4 months of hospitalization for COVID-19, a significant proportion of patients reported new symptoms and abnormalities in lung scans were common. Further research is needed to understand the long-term consequences of COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Biochemistry & Molecular Biology

Post-acute COVID-19 syndrome

Ani Nalbandian et al.

Summary: SARS-CoV-2 is responsible for the COVID-19 pandemic, causing global healthcare crises. Recovery from COVID-19 may lead to persistent symptoms and long-term complications, prompting the need for multidisciplinary care and follow-up for survivors.

NATURE MEDICINE (2021)

Article Critical Care Medicine

Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study

Paul Aveyard et al.

Summary: The study found that patients with certain respiratory diseases had a higher risk of hospitalization and death from COVID-19, while the risk of severe COVID-19 in asthma patients was relatively small. The use of inhaled steroids may be associated with a slightly increased risk of severe COVID-19.

LANCET RESPIRATORY MEDICINE (2021)

Article Critical Care Medicine

Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries

Ankit Bharat et al.

Summary: This study found that lung transplantation is the only option for survival in some severe, unresolving COVID-19-associated ARDS patients, and the procedure can be done successfully with good early post-transplantation outcomes in carefully selected patients.

LANCET RESPIRATORY MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation

Lorriana E. Leard et al.

Summary: Lung transplant is a crucial treatment option for patients with advanced lung diseases, but there are challenges and ethical dilemmas in the process of referral, evaluation, and candidacy determination. The International Society for Heart and Lung Transplantation has updated consensus documents to assist providers in identifying, evaluating, and selecting potential candidates for lung transplant, addressing ethical considerations, and acknowledging variability in risk acceptance among transplant centers.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

Article Biochemistry & Molecular Biology

Long COVID in a prospective cohort of home-isolated patients

Bjorn Blomberg et al.

Summary: An analysis of patients with SARS-CoV-2 infections in Bergen, Norway, revealed that a high proportion of patients experienced long-term COVID symptoms at 6 months, even though they were relatively young and had only mild to moderate acute COVID-19 symptoms. This highlights the significance of infection control measures, such as vaccination.

NATURE MEDICINE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

CT of Post-Acute Lung Complications of COVID-19

Joshua J. Solomon et al.

Summary: The acute course of COVID-19 varies from asymptomatic infection to fulminant respiratory failure, with potential long-term lung disease including persistent symptoms and CT abnormalities. Treatments under investigation include antifibrotic agents for prevention of lung fibrosis after COVID-19.

RADIOLOGY (2021)

Article Medicine, Research & Experimental

Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection

Hyung J. Chun et al.

Summary: This study found that biological factors related to neutrophil activation, fibrosis signaling, and alveolar repair may be novel therapeutic or prognostic targets for individuals recovering from COVID-19 with persistent respiratory symptoms.

JCI INSIGHT (2021)

Review Health Care Sciences & Services

Long COVID-19 Pulmonary Sequelae and Management Considerations

Afroditi K. Boutou et al.

Summary: The COVID-19 pandemic and ARDS have caused a severe global health crisis, with evidence showing that survivors may develop long-term consequences known as the long-COVID-19 syndrome, which affect multiple organs with a variety of symptoms. Management strategies, including corticosteroids, antifibrotic treatment, and pulmonary rehabilitation, are key in improving outcomes for these patients.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Review Medicine, General & Internal

Asthma and COVID-19: review of evidence on risks and management considerations

Jamie Hartmann-Boyce et al.

Summary: The evidence on the association between COVID-19 and asthma is limited, necessitating further research on possible interventions to support asthma care. Current consensus suggests continuing asthma medications and exploring self-management and remote interventions during disruptions in asthma care caused by the pandemic.

BMJ EVIDENCE-BASED MEDICINE (2021)

Article Respiratory System

Persistent Post-COVID-19 Interstitial Lung Disease An Observational Study of Corticosteroid Treatment

Katherine Jane Myall et al.

Summary: Following SARS-CoV-2 infection, some patients develop persistent radiological inflammatory lung disease and functional deficits. Early treatment with corticosteroids is well tolerated and associated with rapid and significant improvement.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Article Respiratory System

Nintedanib treatment for pulmonary fibrosis after coronavirus disease 2019

Hiroaki Ogata et al.

Summary: A 78-year-old Japanese woman without a smoking history suffered from severe COVID-19, requiring mechanical ventilation and developing pulmonary fibrosis. She was gradually able to improve her respiratory function with methylprednisolone and nintedanib treatment, but still needed oxygen therapy.

RESPIROLOGY CASE REPORTS (2021)

Article Respiratory System

'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19

Swapna Mandal et al.

Summary: Following discharge from hospital, a significant number of COVID-19 patients continue to experience persistent symptoms such as breathlessness, cough, fatigue, and depression. Some patients also show elevated levels of biomarkers indicating ongoing health issues. Chest radiographs reveal abnormalities in a considerable portion of patients, with a small percentage showing deterioration.

THORAX (2021)

Review Respiratory System

Post-COVID lung fibrosis: The tsunami that will follow the earthquake

Zarir F. Udwadia et al.

Summary: This article discusses potential pulmonary sequelae post-COVID-19, which may progress to serious conditions such as PC-ILD. It also introduces clinical, laboratory, and radiographic clues at presentation that could help predict future lung fibrosis development. Responsible use of antifibrotic drugs is discussed, along with the biological rationale and potential roles in specific patient groups.

LUNG INDIA (2021)

Review Virology

Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19

Chi Zhang et al.

Summary: The article introduces the potential mechanism of pulmonary fibrosis caused by the COVID-19 virus and discusses the role of three signaling pathways related to fibrosis in the lungs. It also explores the potential therapeutic value of two drugs for COVID-19-induced pulmonary fibrosis.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Respiratory System

Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia

Rebecca F. D'Cruz et al.

Summary: A standardized approach to assessing COVID-19 survivors has not been established due to limited data on medium- and long-term outcomes. This study found that persistent symptoms, adverse mental health outcomes, and physiological impairment are common 2 months after severe COVID-19 pneumonia. Follow-up chest radiography may not effectively monitor recovery, highlighting the importance of holistic face-to-face assessments for early recognition and management of post-COVID-19 sequelae.

ERJ OPEN RESEARCH (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Influence of fat deposition on T1 mapping of the pancreas: evaluation by dual-flip-angle MR imaging with and without fat suppression

Mayumi Higashi et al.

RADIOLOGIA MEDICA (2020)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Microbiology

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs

Sangeun Jeon et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Editorial Material Respiratory System

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge

Xiaoneng Mo et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study

Yuhui Wang et al.

RADIOLOGY (2020)

Article Critical Care Medicine

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

Peter M. George et al.

LANCET RESPIRATORY MEDICINE (2020)

Letter Respiratory System

Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection

Justine Frija-Masson et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Letter Medicine, General & Internal

Persistent Symptoms in Patients After Acute COVID-19

Angelo Carfi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

High Resolution CT Imaging Dynamic Follow-Up Study of Novel Coronavirus Pneumonia

Xuefang Lu et al.

FRONTIERS IN MEDICINE (2020)

Article Critical Care Medicine

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease An International Multicenter Study

Thomas M. Drake et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Editorial Material Medicine, General & Internal

Post-COVID-19 pneumonia pulmonary fibrosis

S. Tale et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

FUNCTIONAL RESPIRATORY EVALUATION IN THE COVID-19 ERA: THE ROLE OF PULMONARY FUNCTION TEST LABORATORIES

Laura GOCHICOA-RANGEL et al.

REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION (2020)

Review Respiratory System

Respiratory follow-up of patients with COVID-19 pneumonia

Peter M. George et al.

THORAX (2020)

Article Critical Care Medicine

Home Oxygen Therapy for Adults with Chronic Lung Disease An Official American Thoracic Society Clinical Practice Guideline

Susan S. Jacobs et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Health Care Sciences & Services

Persistent symptoms after Covid-19: qualitative study of 114 long Covid patients and draft quality principles for services

Emma Ladds et al.

BMC HEALTH SERVICES RESEARCH (2020)

Article Endocrinology & Metabolism

COVID-19 pandemic and its recovery time of patients in India: A pilot study

Manash Pratim Barman et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)

Review Respiratory System

Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies

Ademola S. Ojo et al.

PULMONARY MEDICINE (2020)

Article Health Care Sciences & Services

Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)

Sarah Batawi et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2019)

Article Medicine, General & Internal

Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome

Wan Beom Park et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2018)

Article Medicine, General & Internal

Functional Disability 5 Years after Acute Respiratory Distress Syndrome

Margaret S. Herridge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Critical Care Medicine

Interstitial lung disease in systemic sclerosis - A simple staging system

Nicole S. L. Goh et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)